As of 2026-03-23, the Relative Valuation of Sigilon Therapeutics, Inc. (SGTX) is (297.88) USD. This relative valuation is based on P/E multiples. With the latest stock price at 22.47 USD, the upside of Sigilon Therapeutics, Inc. based on Relative Valuation is -1425.7%.
The range of the Relative Valuation is (270.16) - (313.22) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 18.3x - 22.6x | 20.0x |
| Forward P/E multiples | 17.5x - 21.2x | 20.4x |
| Fair Price | (270.16) - (313.22) | (297.88) |
| Upside | -1302.3% - -1493.9% | -1425.7% |
| Date | P/E |